Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men

Chlamydia pneumoniae (C pn) infection causes an acute inflammation in the respiratory system that may become persistent, but little is known about the long-term respiratory effects of C pn infections. Aim: To estimate the long term respiratory effects of C pn with change in forced expiratory volume in one second (FEV1) and forced expiratory capacity (FVC) as a main outcome variable.

Chlamydia Detection Device Gets Funding Injection

A Tyneside company has been awarded government funding to develop unique mobile devices which could dramatically improve the detection of sexually transmitted diseases (STDs) like Chlamydia.

OJ-Bio Ltd in was awarded £111,150 by the Technology Strategy Board, to develop handheld wireless diagnostic units and biochips for rapid on-the-spot detection of STDS using bodily fluids such as blood, urine and saliva.

Little uptake of chlamydia screening

A review of Medicare data for southern NSW between 2004-2008 found that while rates of chlamydia testing increased in general practice, the overall percentage of tests performed per visit remained low.

Public health researchers say the testing patterns seen suggest that current guidelines for opportunistic screening of young people for chlamydia have not been accepted by rural GPs.

UTSA scientist wins grant to combat chlamydia

Chlamydia is a sexually transmitted disease that affects more than 90 million people around the world. Now, scientists at the University of Texas at San Antonio are one step closer to finding a way to battle its devastating effects.

Chlamydia can wreak havoc long after the bacteria itself is eradicated.

Scientists at UTSA have received a two-year, $140,000 grant from the National Institutes of Health. The goal of their study is to find ways to counteract the side effects of the disease, in particular, damage to the reproductive system.